Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors

Abstract While surgery is at the foundation of cancer treatment, its access is limited in low-income countries. Here, we describe development of a low-cost alternative therapy based on intratumoral ethanol injection suitable for resource-limited settings. Although ethanol-based tumor ablation is suc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Robert Morhard, Corrine Nief, Carlos Barrero Castedo, Fangyao Hu, Megan Madonna, Jenna L. Mueller, Mark W. Dewhirst, David F. Katz, Nirmala Ramanujam
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/584c311f91c847edabf9b9ce015fe3e2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:584c311f91c847edabf9b9ce015fe3e2
record_format dspace
spelling oai:doaj.org-article:584c311f91c847edabf9b9ce015fe3e22021-12-02T12:32:08ZDevelopment of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors10.1038/s41598-017-09371-22045-2322https://doaj.org/article/584c311f91c847edabf9b9ce015fe3e22017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-09371-2https://doaj.org/toc/2045-2322Abstract While surgery is at the foundation of cancer treatment, its access is limited in low-income countries. Here, we describe development of a low-cost alternative therapy based on intratumoral ethanol injection suitable for resource-limited settings. Although ethanol-based tumor ablation is successful in treating hepatocellular carcinomas, the necessity for multiple treatments, injection of large fluid volumes, and decreased efficacy in treatment of non-capsulated tumors limit its applicability. To address these limitations, we investigated an enhanced ethanol ablation strategy to retain ethanol within the tumor through the addition of ethyl cellulose. This increases the viscosity of injected ethanol and forms an ethanol-based gel-phase upon exposure to the aqueous tumor environment. This technique was first optimized to maximize distribution volume, using tissue-simulating phantoms. Then, chemically-induced epithelial tumors in the hamster cheek pouch were treated. As controls, pure ethanol injections of either four times or one-fourth the tumor volume induced complete regression of 33% and 0% of tumors, respectively. In contrast, ethyl cellulose-ethanol injections of one-fourth the tumor volume induced complete regression in 100% of tumors. These results contribute to proof-of-concept for enhanced ethanol ablation as a novel and effective alternative to surgery for tumor treatment, with relevance to resource-limited settings.Robert MorhardCorrine NiefCarlos Barrero CastedoFangyao HuMegan MadonnaJenna L. MuellerMark W. DewhirstDavid F. KatzNirmala RamanujamNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Robert Morhard
Corrine Nief
Carlos Barrero Castedo
Fangyao Hu
Megan Madonna
Jenna L. Mueller
Mark W. Dewhirst
David F. Katz
Nirmala Ramanujam
Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors
description Abstract While surgery is at the foundation of cancer treatment, its access is limited in low-income countries. Here, we describe development of a low-cost alternative therapy based on intratumoral ethanol injection suitable for resource-limited settings. Although ethanol-based tumor ablation is successful in treating hepatocellular carcinomas, the necessity for multiple treatments, injection of large fluid volumes, and decreased efficacy in treatment of non-capsulated tumors limit its applicability. To address these limitations, we investigated an enhanced ethanol ablation strategy to retain ethanol within the tumor through the addition of ethyl cellulose. This increases the viscosity of injected ethanol and forms an ethanol-based gel-phase upon exposure to the aqueous tumor environment. This technique was first optimized to maximize distribution volume, using tissue-simulating phantoms. Then, chemically-induced epithelial tumors in the hamster cheek pouch were treated. As controls, pure ethanol injections of either four times or one-fourth the tumor volume induced complete regression of 33% and 0% of tumors, respectively. In contrast, ethyl cellulose-ethanol injections of one-fourth the tumor volume induced complete regression in 100% of tumors. These results contribute to proof-of-concept for enhanced ethanol ablation as a novel and effective alternative to surgery for tumor treatment, with relevance to resource-limited settings.
format article
author Robert Morhard
Corrine Nief
Carlos Barrero Castedo
Fangyao Hu
Megan Madonna
Jenna L. Mueller
Mark W. Dewhirst
David F. Katz
Nirmala Ramanujam
author_facet Robert Morhard
Corrine Nief
Carlos Barrero Castedo
Fangyao Hu
Megan Madonna
Jenna L. Mueller
Mark W. Dewhirst
David F. Katz
Nirmala Ramanujam
author_sort Robert Morhard
title Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors
title_short Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors
title_full Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors
title_fullStr Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors
title_full_unstemmed Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors
title_sort development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/584c311f91c847edabf9b9ce015fe3e2
work_keys_str_mv AT robertmorhard developmentofenhancedethanolablationasanalternativetosurgeryintreatmentofsuperficialsolidtumors
AT corrinenief developmentofenhancedethanolablationasanalternativetosurgeryintreatmentofsuperficialsolidtumors
AT carlosbarrerocastedo developmentofenhancedethanolablationasanalternativetosurgeryintreatmentofsuperficialsolidtumors
AT fangyaohu developmentofenhancedethanolablationasanalternativetosurgeryintreatmentofsuperficialsolidtumors
AT meganmadonna developmentofenhancedethanolablationasanalternativetosurgeryintreatmentofsuperficialsolidtumors
AT jennalmueller developmentofenhancedethanolablationasanalternativetosurgeryintreatmentofsuperficialsolidtumors
AT markwdewhirst developmentofenhancedethanolablationasanalternativetosurgeryintreatmentofsuperficialsolidtumors
AT davidfkatz developmentofenhancedethanolablationasanalternativetosurgeryintreatmentofsuperficialsolidtumors
AT nirmalaramanujam developmentofenhancedethanolablationasanalternativetosurgeryintreatmentofsuperficialsolidtumors
_version_ 1718394157568884736